ALIZABETHE WHIPPLE: Open Payments
NPI 1295365286 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 10 payments from 9 companies in 2025. Trend: 2023 $429 · 2024 $301 · 2025 $475
Food & beverage: $386Education: $89
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 2 | $216 |
| Janssen Biotech, Inc. | 1 | $89 |
| Boston Scientific Corporation | 1 | $39 |
| CSL Behring | 1 | $27 |
| Biogen, Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Sandoz Inc. | 1 | $16 |
Products named: BRIUMVI, TREMFYA, LEQEMBI, Varithena Administration Pack, Hizentra, FABRAZYME, Fabhalta, JUBBONTI.
Industry payments across TX — which companies pay providers there.
